Nuvalent Inc vs S&P Global Inc — how do they compare? Nuvalent Inc trades at $123.96 (market cap $9.81B), while S&P Global Inc trades at $431.26 (market cap $132.71B). The key difference: S&P Global Inc is far larger — about 13.5× Nuvalent Inc's market cap, and S&P Global Inc pays a 0.87% dividend while Nuvalent Inc pays none. Which is the better fit depends on your goals.
| NUVL | SPGI | |
|---|---|---|
Market Cap | $9.81B | $132.71B |
Sector | Technology | Financials |
52-Week High | $123.96 | $534.79 |
52-Week Low | $72.16 | $370.42 |
Enterprise Value | $8.52B | $144.68B |
Dividend Yield | — | 0.87% |
Trailing returns across standard periods
Latest headlines on both assets
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →S&P Global provides data and benchmarks to capital and commodity market participants. In 2021 and excluding IHS Markit, S&P Ratings was over 45% of the firm's revenue and over 55% of the firm's operating income. S&P Ratings is the largest credit rating agency in the world. The firm's other segments include Market Intelligence, Indices, and Platts. Market Intelligence provides desktop tools and other data solutions to investment banks, corporations, and other entities. Indices provides benchmarks for financial markets and is monetized through subscriptions, asset-based fees, and transaction-based royalties. Platts provides benchmarks to commodity markets, principally petroleum.
Read more on SPGI →